LTZ Therapeutics is a California-based biotechnology company that researches and develops novel immunotherapies for the treatment of cancer and autoimmune diseases.
$17M
Apr 06, 2022
-
Adlai Nortye is a China-based biopharmaceutical company that develops and commercializes novel therapies for the treatment of cancer and metabolic diseases.
$100M
Jul 12, 2021
-
CANbridge is a biopharmaceutical company that develops and commercializes drugs for the treatment of cancer and orphan diseases.
$98M
Feb 17, 2020
-
ECO is a biopharmaceutical company that researches, develops and commercializes oncology products for the treatment of cancer.
$71M
Dec 01, 2019
-
Frequently Asked Questions about Hangzhou Tigermed Consulting Co., Ltd.
What is Hangzhou Tigermed Consulting Co., Ltd. investing in?
Hangzhou Tigermed Consulting Co., Ltd. has invested in 9 companies including GCP ClinPlus, LTZ and Adlai Nortye
What company did Hangzhou Tigermed Consulting Co., Ltd. invest in?
Hangzhou Tigermed Consulting Co., Ltd. invested in a total 9 companies including GCP ClinPlus, LTZ and Adlai Nortye
What are the top 5 investments by Hangzhou Tigermed Consulting Co., Ltd.?
The top companies in which Hangzhou Tigermed Consulting Co., Ltd. invested are GCP ClinPlus, LTZ, Adlai Nortye, CANbridge and EOC Pharma
